222 related articles for article (PubMed ID: 30918952)
1. Systematic Review With Meta-analysis: Epidemiology of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease.
Zou ZY; Shen B; Fan JG
Inflamm Bowel Dis; 2019 Oct; 25(11):1764-1772. PubMed ID: 30918952
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis: prevalence of, and risk factors for, non-alcoholic fatty liver disease in patients with inflammatory bowel disease.
Zamani M; Alizadeh-Tabari S; Singh S; Loomba R
Aliment Pharmacol Ther; 2022 Apr; 55(8):894-907. PubMed ID: 35274325
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study.
Abenavoli L; Spagnuolo R; Scarlata GGM; Scarpellini E; Boccuto L; Luzza F
Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38003983
[No Abstract] [Full Text] [Related]
4. Steroid Use and Risk of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-analysis.
Trivedi HD; Lopes EW; Glissen Brown J; Dudani S; Lai M; Feuerstein JD; Pierce TT
J Clin Gastroenterol; 2023 Jul; 57(6):610-616. PubMed ID: 35648974
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of metabolic syndrome in patients with inflammatory bowel disease: a systematic review and meta-analysis.
Shen Z; Zhang M; Liu Y; Ge C; Lu Y; Shen H; Zhu L
BMJ Open; 2024 Mar; 14(3):e074659. PubMed ID: 38453206
[TBL] [Abstract][Full Text] [Related]
6. Systematic Review and Meta-Analysis: Prevalence of Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Patients with Inflammatory Bowel Disease.
Navarro P; Gutiérrez-Ramírez L; Tejera-Muñoz A; Arias Á; Lucendo AJ
Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960160
[TBL] [Abstract][Full Text] [Related]
7. Crohn's Disease is a Greater Risk Factor for Nonalcoholic Fatty Liver Disease Compared to Ulcerative Colitis: A Systematic Review.
Kodali A; Okoye C; Klein D; Mohamoud I; Olanisa OO; Parab P; Chaudhary P; Mukhtar S; Moradi A; Hamid P
Cureus; 2023 Aug; 15(8):e42995. PubMed ID: 37671212
[TBL] [Abstract][Full Text] [Related]
8. Crohn´s disease is an independent risk factor for liver fibrosis in patients with inflammatory bowel disease and non-alcoholic fatty liver disease.
Martínez-Domínguez SJ; García-Mateo S; Gargallo-Puyuelo CJ; Gallego Llera B; Refaie E; Callau P; Mendi C; Baptista PM; Hernández Ainsa M; Arroyo-Villarino MT; López de la Cruz J; Martínez-García J; Alfambra E; Simón Marco MÁ; Ampuero J; Gomollón F
Eur J Intern Med; 2024 Feb; 120():99-106. PubMed ID: 37872034
[TBL] [Abstract][Full Text] [Related]
9. Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease.
Hyun HK; Lee HW; Park J; Park SJ; Park JJ; Kim TI; Lee JS; Kim BK; Park JY; Kim DY; Ahn SH; Kim SU; Cheon JH
Gut Liver; 2024 Mar; 18(2):294-304. PubMed ID: 37203442
[TBL] [Abstract][Full Text] [Related]
10. The impact of nonalcoholic fatty liver disease on inflammatory bowel disease-related hospitalization outcomes: a systematic review.
Boustany A; Rahhal R; Mitri J; Onwuzo S; Abou Zeid HK; Baffy G; Martel M; Barkun AN; Asaad I
Eur J Gastroenterol Hepatol; 2023 Oct; 35(10):1067-1074. PubMed ID: 37577829
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and risk of nonalcoholic fatty liver disease among adult psoriatic patients: A systematic review, meta-analysis, and trial sequential analysis.
Hu J; Shao Y; Gui C; Xiao Y; Li L; Li Z
Medicine (Baltimore); 2024 May; 103(18):e38007. PubMed ID: 38701269
[TBL] [Abstract][Full Text] [Related]
12. The evaluation of liver abnormalities in inflammatory bowel disease patients.
McHenry S
Curr Opin Gastroenterol; 2023 Jul; 39(4):287-293. PubMed ID: 37144524
[TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease.
Sartini A; Gitto S; Bianchini M; Verga MC; Di Girolamo M; Bertani A; Del Buono M; Schepis F; Lei B; De Maria N; Villa E
Cell Death Dis; 2018 Jan; 9(2):87. PubMed ID: 29367619
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-analysis.
Zamani M; Alizadeh-Tabari S; Chitkara P; Singh S; Loomba R
Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2789-2796. PubMed ID: 36871771
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle Together.
Maresca R; Mignini I; Varca S; Calvez V; Termite F; Esposto G; Laterza L; Scaldaferri F; Ainora ME; Gasbarrini A; Zocco MA
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542249
[TBL] [Abstract][Full Text] [Related]
16. Association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a nationwide population‑based cohort study.
Wang YH; Chung CH; Huang TY; Chang CF; Yang CW; Chien WC; Cheng YC
Intest Res; 2024 Feb; ():. PubMed ID: 38373704
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Hepatobiliary Manifestations in Inflammatory Bowel Disease: A GRADE Assessed Systematic Review and Meta-Analysis of more than 1.7 Million Patients.
Beheshti Maal A; Shahrbaf MA; Sadri B; Hossein-Khannazer N; Mansournia MA; Vosough M
J Crohns Colitis; 2024 Mar; 18(3):360-374. PubMed ID: 37695111
[TBL] [Abstract][Full Text] [Related]
18. Urolithiasis in patients with inflammatory bowel disease: A systematic review and meta-analysis of 13,339,065 individuals.
Abdulrhman A; Alsweed A; Alotaibi MR; Aldakhil AY; Alahmadi SF; Albishri SM; Alhmed NI
Medicine (Baltimore); 2023 Jun; 102(24):e33938. PubMed ID: 37327280
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of nonalcoholic fatty liver disease in pediatrics and adolescents: a systematic review and meta-analysis.
Lee EJ; Choi M; Ahn SB; Yoo JJ; Kang SH; Cho Y; Song DS; Koh H; Jeon DW; Lee HW
World J Pediatr; 2024 May; ():. PubMed ID: 38771552
[TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic fatty liver disease and coexisting depression, anxiety and/or stress in adults: a systematic review and meta-analysis.
Shea S; Lionis C; Kite C; Lagojda L; Uthman OA; Dallaway A; Atkinson L; Chaggar SS; Randeva HS; Kyrou I
Front Endocrinol (Lausanne); 2024; 15():1357664. PubMed ID: 38689730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
